Aaron Nelson, MD, PhD
Aaron Nelson, MD, PhD
General Partner

Aaron is a General Partner at dRx Capital, as well as a Strategic Project Leader within the Trials of The Future team of Novartis Pharmaceuticals.

In recent years, Aaron has worked on technology strategy for clinical trial teams within Novartis. This work has led him to conclude that mobile, cloud, and Health IT technologies provide transformative opportunities in the clinical research and pharmaceutical industries. Aaron has led projects building upon these themes across multiple Business Units within Novartis, often by collaborations or investments in early-stage partner companies.

Previously, Aaron led laboratory teams at Novartis, investigating the biological bases for drug toxicity. Aaron studied medicine at Tufts University, cell and microbiology at the University of Pennsylvania and the Karolinska Institute, and completed his undergraduate studies at Cornell University.

 
 
 
© 2016 dRx Capital, a joint investment company of Novartis & Qualcomm Incorporated. Novartis is a registered trademark of Novartis AG. Qualcomm is a trademark of Qualcomm Incorporated, registered in the United States and other countries. All Rights Reserved.